India to Sudan Pharmaceutical Export
Bilateral Trade Intelligence · $104.8M Total Trade · 228 Exporters · 419 Buyers · DGFT Verified · Updated March 2026
India exported $104.8M worth of pharmaceutical formulations to Sudan across 9,384 verified shipments, sourced from 228 Indian exporters supplying 419 Sudan buyers. The top exporters are SYMBIOSIS PHARMACEUTICALS PRIVATE LIMITED ($10.6M) and SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI ($8.0M). The leading products are Vaccine ($5.3M) and Artemether ($923K). Average shipment value: $11.2K.
Top Pharmaceutical Formulations — India to Sudan
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Other Mix Vaccine-viral Vaccine | $5.3M | 5.0% |
| 2 | Symclav-625 Tablet Export 1x10. Batch No | $3.5M | 3.3% |
| 3 | Tprost | $2.2M | 2.1% |
| 4 | Symtrax-1gm Injection Export 1x50. Batch No. & | $2.0M | 1.9% |
| 5 | Amisym Injection Export 1x50. Batch No. & All | $1.6M | 1.5% |
| 6 | Mr Vaccine Measles and Rubella Vaccine Combined Vial of 5 Doses with Diluent wi… | $1.3M | 1.2% |
| 7 | Symclox-500 Injection Export 1x50. Batch No. & | $1.1M | 1.0% |
| 8 | Artemether 80 + Lumafantrine 480 MG | $923.2K | 0.9% |
| 9 | S359349 Mr Vaccine Measles and Rubella | $889.0K | 0.8% |
| 10 | Aurovisc[hydroxypropyl Methylcellulose O | $883.7K | 0.8% |
| 11 | Cefpodoxime Proxetil 200 MG Tablets | $857.9K | 0.8% |
| 12 | Metrosym 100ml 100ml. Batch No. & All | $855.8K | 0.8% |
| 13 | Amidol, Each Uncoated Tablet Contains : Paracetamol BP 500mg, Excipients (-qs) | $774.8K | 0.7% |
| 14 | Sterile Ceftriaxone Sodium USP Ceftriaxone for Injection USP 1 Gm and Sterile W… | $759.4K | 0.7% |
| 15 | Sodium Valproate IP 200 MG | $720.9K | 0.7% |
India exports 20+ pharmaceutical formulations to Sudan with a combined trade value of $104.8M. Key products include Vaccine ($5.3M), Artemether ($923K), Cefpodoxime ($858K), Paracetamol ($775K), Ceftriaxone ($759K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 9,384 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — India to Sudan Trade Routes
These are the top pharmaceutical products exported from India to Sudan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Sudan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Vaccine ($5.3M), Artemether ($923K), Cefpodoxime ($858K), Paracetamol ($775K), Ceftriaxone ($759K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Indian Exporters to Sudan
228 Indian pharmaceutical companies export finished formulations to Sudan. Leading exporters include Symbiosis Pharmaceuticals Private Limited, Scott-edil Advance Research Laboratories & Educati, Serum Institute Of India Private Limited, Lincoln Pharmaceuticals Ltd. The top exporter accounts for 10.1% of total India–Sudan pharma exports. Source: Indian Customs (DGFT).
Top Sudan Buyers from India
419 companies in Sudan import pharmaceutical formulations from India. Top buyers include Indigo Pharmaceuticals Limited, Xxicexxsupxxy Dxxisixx, Amipharma Laboratories Ltd, To The Director Of. The largest buyer accounts for 10.1% of India–Sudan pharma imports. Source: Indian Customs (DGFT).
Port Analysis — India to Sudan Pharmaceutical Shipments
Indian Export Ports
Sudan Import Ports
Trade Statistics
Other Destinations
Product Routes
FAQ — India to Sudan Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Sudan?
India exported pharmaceuticals worth $104.8M to Sudan across 9,384 verified shipments.
Who are the top Indian pharmaceutical exporters to Sudan?
1. SYMBIOSIS PHARMACEUTICALS PRIVATE LIMITED — $10.6M. 2. SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — $8.0M. 3. SERUM INSTITUTE OF INDIA PRIVATE LIMITED — $6.1M. Total: 228 suppliers.
Which companies in Sudan import pharmaceuticals from India?
1. INDIGO PHARMACEUTICALS LIMITED — $10.6M. 2. XXICEXXSUPXXY DXXISIXX — $5.7M. 3. AMIPHARMA LABORATORIES LTD — $5.4M. 419 buyers total.
What pharmaceutical products does India export most to Sudan?
1. Other Mix Vaccine-viral Vaccine ($5.3M, 5.0%); 2. Symclav-625 Tablet Export 1x10. Batch No ($3.5M, 3.3%); 3. Tprost ($2.2M, 2.1%); 4. Symtrax-1gm Injection Export 1x50. Batch No. & ($2.0M, 1.9%); 5. Amisym Injection Export 1x50. Batch No. & All ($1.6M, 1.5%)
Which ports handle pharmaceutical shipments from India to Sudan?
Export: NHAVA SHEVA SEA (INNSA1), GRFL SAHNEWAL LUDHIANA ICD, CHENNAI AIR, MUNDRA SEA, SERUM BIOPHARMA PARK SEZ. Import: Port Sudan, PORT SUDAN, Mombasa, KHARTOUM, JUBA.
Why does Sudan import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $104.8M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Sudan?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Sudan pharmaceutical trade?
$11.2K per consignment across 9,384 shipments.
How many Indian pharmaceutical companies export to Sudan?
228 Indian companies. Largest: SYMBIOSIS PHARMACEUTICALS PRIVATE LIMITED with $10.6M.
How can I find verified Indian pharmaceutical suppliers for Sudan?
TransData Nexus covers 228 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Sudan Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 9,384 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Sudan identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 9,384 verified shipments from 228 Indian exporters to 419 Sudan buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
228 Exporters
419 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists